ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

1706, 2025

PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study

Chrystal Johnson2025-06-16T13:59:16-07:002025-06-17|

News & Events PredictrPK® ADA, [...]

405, 2025

Prometheus Laboratories Presents Novel Data on Precision-Guided Care in IBD at DDW® 2025

Chrystal Johnson2025-05-01T17:07:18-07:002025-05-04|

News & Events Prometheus Laboratories [...]

2904, 2025

Prometheus Laboratories Launches First Pre-Therapy Test to Predict Likelihood of Biologic Response

Chrystal Johnson2025-04-29T08:23:51-07:002025-04-29|

News & Events Prometheus Laboratories [...]

104, 2025

Prometheus Laboratories Launches New Anser® Test for Risankizumab

Chrystal Johnson2025-03-31T11:05:14-07:002025-04-01|

News & Events Prometheus [...]

2002, 2025

Prometheus Laboratories Unveils New Data on Precision-Guided Care for IBD at ECCO’25 Congress

Chrystal Johnson2025-02-20T05:27:14-08:002025-02-20|

News & Events Prometheus [...]

2005, 2024

Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive Economic Impact of Precision-Guided Care at DDW® 2024

John Walker2024-05-20T07:50:41-07:002024-05-20|

News & Events Prometheus [...]